Tissue- and cell-specific co-localization of intracellular gelatinolytic activity and matrix metalloproteinase

Journal of Histochemistry and Cytochemistry

Volumn 61, Issue 6, 2013, Pages 444-461

  Solli, Ann Iren ^a   Fadnes, Bodil ^a   Winberg, Jan Olof ^a   Uhlin Hansen, Lars ^a,b   Hadler Olsen, Elin ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Gelatinolytic activity; Homeostasis; Intracellular; MMP 2

Indexed keywords

EDETIC ACID; GELATIN; GELATINASE A; METALLOPROTEINASE INHIBITOR; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE;

ADRENAL GLAND; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CELL SPECIFICITY; CELLULAR DISTRIBUTION; ELECTRON MICROSCOPY; ENZYME ACTIVITY; EPITHELIUM CELL; ESOPHAGUS; GONAD; HEART; HEART MUSCLE CELL; IMMUNOGOLD LABELING; IMMUNOHISTOCHEMISTRY; INTESTINE; KIDNEY; KIDNEY CELL; LIVER; LIVER CELL; LUNG; MOUSE; MOUTH MUCOSA; NONHUMAN; PANCREAS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SALIVARY GLAND; SKIN; SPLEEN; THYROID GLAND; TISSUE DISTRIBUTION; WESTERN BLOTTING; ZYMOGRAPHY;

GELATINOLYTIC ACTIVITY; HOMEOSTASIS; INTRACELLULAR; MMP-2;

ANIMALS; EDETIC ACID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GELATIN; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED C57BL; PROTEOLYSIS;

EID: 84879473301     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/0022155413484765     Document Type: Article

References (45)

1. Ali M.A., Chow AK, Kandasamy AD, Fan X, West LJ, Crawford BD, Simmen T., Schulz R. 2012. Mechanisms of cytosolic targeting of matrix metalloproteinase-2. J Cell Physiol. 227:3397-3404.
2. Ali M.A., Fan X, Schulz R. 2011. Cardiac sarcomeric proteins: novel intracellular targets of matrix metalloproteinase-2 in heart disease. Trends Cardiovasc Med. 21:112-118.
3. Bannikov G.A., Karelina TV, Collier IE, Marmer BL, Goldberg GI. 2002. Substrate binding of gelatinase B induces its enzymatic activity in the presence of intact propeptide. J BiolChem. 277:16022-16027.
4. Beckstead JH. 1994. A simple technique for preservation of fixation-sensitive antigens in paraffin-embedded tissues. J HistochemCytochem. 42:1127-1134.
5. Butler G.S., Overall CM. 2009. Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics. Biochemistry. 48:10830-10845.
6. Cauwe B., Opdenakker G. 2010. Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases. Crit Rev Biochem Mol Biol. 45:351-423.
7. Cavallo-Medved D, Rudy D, Blum G, Bogyo M, Caglic D, Sloane BF. 2009. Live-cell imaging demonstrates extracellular matrix degradation in association with active cathepsin B in caveolae of endothelial cells during tube formation. Exp Cell Res. 315:1234-1246.
8. Coopman P.J., Do MT, Thompson EW, Mueller SC. 1998. Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity. Clin Cancer Res. 4:507-515.
9. D'Alessio S, Ferrari G, Cinnante K, Scheerer W, Galloway AC, Roses D.F., Rozanov DV, Remacle AG, Oh ES, Shiryaev SA, et al. 2008. Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism. J Biol Chem. 283:87-99.
10. Dean D.D., Schwartz Z, Schmitz J, Muniz OE, Lu Y, Calderon F, Howell D.S., Boyan BD. 1996. Vitamin D regulation of metalloproteinase activity in matrix vesicles 3. Connect Tissue Res. 35:331-336.
11. Eisenach P.A., Roghi C, Fogarasi M, Murphy G, English WR. 2010. MT1-MMP regulates VEGF-A expression through a complex with VEGFR-2 and Src. J Cell Sci. 123:4182-4193.
12. Fedarko N.S., Jain A, Karadag A, Fisher LW. 2004. Three small integrin binding ligand N-linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases. FASEB J. 18:734-736.
13. Freise C., Erben U, Muche M, Farndale R, Zeitz M, Somasundaram R, Ruehl M. 2009. The alpha 2 chain of collagen type VI sequesters latent proforms of matrix-metalloproteinases and modulates their activation and activity. Matrix Biol. 28:480-489.
14. Gialeli C., Theocharis AD, Karamanos NK. 2011. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting 1. FEBS J. 278:16-27.
15. Ginestra A., Monea S, Seghezzi G, Dolo V, Nagase H, Mignatti P, Vittorelli ML. 1997. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells 2. J Biol Chem. 272:17216-17222.
16. Hadler-Olsen E, Fadnes B, Sylte I, Uhlin-Hansen L, Winberg JO. 2011. Regulation of matrix metalloproteinase activity in health and disease 1. FEBS J. 278:28-45.
17. Hadler-Olsen E, Kanapathippillai P, Berg E, Svineng G, Winberg JO, Uhlin-Hansen L. 2010. Gelatin in situ zymography on fixed, paraffin-embedded tissue: zinc and ethanol fixation preserve enzyme activity. J Histochem Cytochem. 58:29-39.
18. Hadler-Olsen E, Wetting HL, Ravuri C, Omair A, Rikardsen O, Svineng G., Kanapathippillai P, Winberg JO, Uhlin-Hansen L. 2011. Organ specific regulation of tumour invasiveness and gelatinolytic activity at the invasive front. Eur J Cancer. 47:305-315.
19. Hadler-Olsen E, Winberg JO, Reinholt FP, Larsen T, Uhlin-Hansen L., Jenssen T, Berg E, Kolset SO. 2011. Proteases in plasma and kidney of db/db mice as markers of diabetesinduced nephropathy. ISRN Endocrinol. 2011:832642.
20. Hansen B., Melkko J, Smedsrod B. 2002. Serum is a rich source of ligands for the scavenger receptor of hepatic sinusoidal endothelial cells. Mol Cell Biochem. 229:63-72.
21. Hill J.W., Poddar R, Thompson JF, Rosenberg GA, Yang Y. 2012. Intranuclear matrix metalloproteinases promote DNA damage and apoptosis induced by oxygen-glucose deprivation in neurons. Neuroscience. 220:277-290.
22. Ip Y.C., Cheung ST, Fan ST. 2007. Atypical localization of membrane type 1-matrix metalloproteinase in the nucleus is associated with aggressive features of hepatocellular carcinoma. Mol Carcinog. 46:225-230.
23. Jain A., Karadag A, Fisher LW, Fedarko NS. 2008. Structural requirements for bone sialoprotein binding and modulation of matrix metalloproteinase-2. Biochemistry. 47:10162-10170.
24. Kobayashi T., Hattori S, Nagai Y, Tajima S, Nishikawa T. 1998. Differential regulation of MMP-2 and MMP-9 gelatinases in cultured human keratinocytes. Dermatology. 197:1-5.
25. Koo B.H., Kim YH, Han JH, Kim DS. 2012. Dimerization of matrix metalloproteinase-2 (MMP-2): functional implication in MMP-2 activation. J Biol Chem. 287:22643-22653.
26. Kwan J.A., Schulze CJ, Wang W, Leon H, Sariahmetoglu M, Sung M, Sawicka J, Sims DE, Sawicki G, Schulz R. 2004. Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro. FASEB J. 18:690-692.
27. Lovett D.H., Mahimkar R, Raffai RL, Cape L, Maklashina E, Cecchini G., Karliner JS. 2012. A novel intracellular isoform of matrix metalloproteinase-2 induced by oxidative stress activates innate immunity. PloS One. 7:e34177.
28. Malla N., Berg E, Uhlin-Hansen L, Winberg JO. 2008. Interaction of pro-matrix metalloproteinase-9/proteoglycan heteromer with gelatin and collagen. J Biol Chem. 283:13652-13665.
29. Malla N., Sjøli S, Winberg JO, Hadler-Olsen E, Uhlin-Hansen L. 2008. Biological and pathobiological functions of gelatinase dimers and complexes. Connect Tissue Res. 49:180-184.
30. Mori H., Gjorevski N, Inman JL, Bissell MJ, Nelson CM. 2009. Self-organization of engineered epithelial tubules by differential cellular motility. Proc Natl Acad Sci U S A. 106:14890-14895.
31. Ono Y., Sorimachi H. 2012. Calpains: an elaborate proteolytic system. Biochim Biophys Acta. 1824:224-236.
32. Osenkowski P., Toth M, Fridman R. 2004. Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP). J Cell Physiol. 200:2-10.
33. Ruta A., Mark B, Edward B, Jawaharlal P, Jianliang Z. 2009. Nuclear localization of active matrix metalloproteinase-2 in cigarette smoke-exposed apoptotic endothelial cells. Exp Lung Res. 35:59-75.
34. Sariahmetoglu M., Crawford BD, Leon H, Sawicka J, Li L, Ballermann B.J., Holmes C, Berthiaume LG, Holt A, Sawicki G, et al. 2007. Regulation of matrix metalloproteinase-2 (MMP-2) activity by phosphorylation. FASEB J. 21:2486-2495.
35. Sela-Passwell N, Rosenblum G, Shoham T, Sagi I. 2010. Structural and functional bases for allosteric control of MMP activities: can it pave the path for selective inhibition? Biochim Biophys Acta. 1803:29-38.
36. Sung M.M., Schulz CG, Wang W, Sawicki G, Bautista-Lopez NL, Schulz R. 2007. Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury. J Mol Cell Cardiol. 43:429-436.
37. Taraboletti G., D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, Dolo V. 2002. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol. 160:673-680.
38. Ten Cate AR, Deporter DA, Freeman E. 1976. The role of fibroblasts in the remodeling of periodontal ligament during physiologic tooth movement. Am J Orthod. 69:155-168.
39. Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G. 2002. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol. 37:375-536.
40. van der Zee E, Everts V, Hoeben K, Beertsen W. 1995. Cytokines modulate phagocytosis and intracellular digestion of collagen fibrils by fibroblasts in rabbit periosteal explants: inverse effects on procollagenase production and collagen phagocytosis. J Cell Sci. 108:3307-3315.
41. Viappiani S., Nicolescu AC, Holt A, Sawicki G, Crawford BD, Leon H., van MT, Schulz R. 2009. Activation and modulation of 72kDa matrix metalloproteinase-2 by peroxynitrite and glutathione. Biochem Pharmacol. 77:826-834.
42. Victor B.C., Sloane BF. 2007. Cysteine cathepsin non-inhibitory binding partners: modulating intracellular trafficking and function. Biol Chem. 388:1131-1140.
43. Vilen S.T., Nyberg P, Hukkanen M, Sutinen M, Ylipalosaari M, Bjartell A., Paju A, Haaparanta V, Stenman UH, Sorsa T, et al. 2008. Intracellular co-localization of trypsin-2 and matrix metalloprotease-9: possible proteolytic cascade of trypsin-2, MMP-9 and enterokinase in carcinoma. Exp Cell Res. 314:914-926.
44. Visse R., Nagase H. 2003. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 92:827-839.
45. Yang Y., Candelario-Jalil E, Thompson JF, Cuadrado E, Estrada EY, Rosell A, Montaner J, Rosenberg GA. 2010. Increased intranuclear matrix metalloproteinase activity in neurons interferes with oxidative DNA repair in focal cerebral ischemia. J Neurochem. 112:134-149. Downloaded from jhc. sagepub. com by Michiel Schotten on June 25, 2013